Cancer and Pregnancy: A Comprehensive Review

by Roxana Schwab, Katharina Anic, Annette Hasenburg
Published 2021-06-01

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions

by Matthias Alexa, Annette Hasenburg, Marco Johannes Battista
Published 2021-03-01

The value of advanced MRI techniques in the assessment of cervical cancer: a review

by Evelyn Dappa, Tania Elger, Annette Hasenburg, Christoph Düber, Marco J. Battista, Andreas M. Hötker
Published 2017-08-01

In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself

by Ines Breuksch, Jonas Welter, Heide-Katharina Bauer, Thorsten Enklaar, Sebastian Frees, Joachim W. Thüroff, Annette Hasenburg, Dirk Prawitt, Walburgis Brenner
Published 2018-06-01

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes

by Anne-Sophie Heimes, Franziska Härtner, Katrin Almstedt, Slavomir Krajnak, Antje Lebrecht, Marco J. Battista, Karolina Edlund, Walburgis Brenner, Annette Hasenburg, Ugur Sahin, Mathias Gehrmann, Jan G. Hengstler, Marcus Schmidt
Published 2020-09-01

Prognostic Impact of Immunoglobulin Kappa C (<i>IGKC</i>) in Early Breast Cancer

by Marcus Schmidt, Karolina Edlund, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Antje Lebrecht, Slavomir Krajnak, Marco J. Battista, Walburgis Brenner, Annette Hasenburg, Jörg Rahnenführer, Mathias Gehrmann, Pirkko-Liisa Kellokumpu-Lehtinen, Ralph M. Wirtz, Heikki Joensuu
Published 2021-07-01

A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors

by Maxim Kebenko, Marie-Elisabeth Goebeler, Martin Wolf, Annette Hasenburg, Ruth Seggewiss-Bernhardt, Barbara Ritter, Beate Rautenberg, Djordje Atanackovic, Andrea Kratzer, James B. Rottman, Matthias Friedrich, Eva Vieser, Stefanie Elm, Ingrid Patzak, Dorothea Wessiepe, Sabine Stienen, Walter Fiedler
Published 2018-08-01

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

by Marcus Schmidt, Veronika Weyer-Elberich, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, Marco J. Battista, Annette Hasenburg, Ugur Sahin, Konstantine T. Kalogeras, Pirkko-Liisa Kellokumpu-Lehtinen, George Fountzilas, Ralph M. Wirtz, Heikki Joensuu
Published 2018-02-01

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

by Jane Bayani, Cindy Q. Yao, Mary Anne Quintayo, Fu Yan, Syed Haider, Alister D’Costa, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros, John M. S. Bartlett
Published 2017-02-01

Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study

by John M. S. Bartlett, Jane Bayani, Elizabeth Kornaga, Keying Xu, Greg R. Pond, Tammy Piper, Elizabeth Mallon, Cindy Q. Yao, Paul C. Boutros, Annette Hasenburg, J. A. Dunn, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Cornelis J. H. van de Velde, Robert C. Stein, Daniel Rea
Published 2021-07-01

Pathway-based subnetworks enable cross-disease biomarker discovery

by Syed Haider, Cindy Q. Yao, Vicky S. Sabine, Michal Grzadkowski, Vincent Stimper, Maud H. W. Starmans, Jianxin Wang, Francis Nguyen, Nathalie C. Moon, Xihui Lin, Camilla Drake, Cheryl A. Crozier, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos J. Markopoulos, Luc Y. Dirix, Caroline Seynaeve, Daniel W. Rea, Arek Kasprzyk, Philippe Lambin, Pietro Lio’, John M. S. Bartlett, Paul C. Boutros
Published 2018-11-01